The Effect of Tranexamic Acid for Total Hip Arthroplasty
NCT ID: NCT02094066
Last Updated: 2014-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2014-03-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Tranexamic Acid in Total Blood Loss During Proximal Femoral Nailing
NCT05359172
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
NCT01683955
Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty
NCT01260818
Tranexamic Acid in Total Knee Replacement
NCT03656445
Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty
NCT04691362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tranexamic acid
preoperative ıv 50 mg/kg tranexamic acid infusion at 45 minutes
tranexamic acid
preoperative ıv 50 mg/kg tranexamic acid infusion at 45 minutes
serum physiologic
preoperative 100 cc serum physiologic
serum physiologic
preoperative 100 cc ıv serum physiologic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tranexamic acid
preoperative ıv 50 mg/kg tranexamic acid infusion at 45 minutes
serum physiologic
preoperative 100 cc ıv serum physiologic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-75 age
* total hip arthroplasty surgery
* regional anesthesia
Exclusion Criteria
* liver and kidney failure
* ischemic heart disease
* coagulopathy
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
seher orbay yasli
resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
seher orbay yasli, resident
Role: PRINCIPAL_INVESTIGATOR
Erciyes university medicine faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes univercity medicine faculty
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012/683
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.